Cooley Advises Horizon Pharma on $660 Million Acquisition of Vidara Therapeutics

San Diego, Calif. – March 27, 2014 – Cooley LLP announced today that it advised Horizon Pharma, Inc. on its acquisition of Dublin-based Vidara Therapeutics International Ltd. for stock and cash valued at approximately $660 million. The resulting company, which will be organized under the laws of Ireland, has a portfolio of four products marketed primarily in the US. The transaction is expected to close by mid-2014.
 
Horizon is a commercial stage, specialty pharmaceutical company that markets DUEXIS®, VIMOVO® and RAYOS®/LODOTRA®, which target unmet therapeutic needs in arthritis, pain and inflammatory diseases. Horizon's strategy is to develop, acquire or in-license additional innovative medicines where it can execute a targeted commercial approach to specific physicians, such as primary care physicians, orthopedic surgeons and rheumatologists, while leveraging its commercial strengths and the infrastructure the company has put in place. Vidara is a specialty pharmaceutical company that markets ACTIMMUNE® in the US and maintains operations both in Dublin, Ireland and in the US. 

About Cooley LLP

Cooley's attorneys solve legal issues for entrepreneurs, investors, financial institutions and established companies. Clients partner with Cooley on transformative deals, complex IP and regulatory matters, and bet-the-company litigation, often where innovation meets the law.

Cooley has more than 750 lawyers across 11 offices in the United States and China.

This content is provided for general informational purposes only, and your access or use of the content does not create an attorney-client relationship between you or your organization and Cooley LLP, Cooley (UK) LLP, or any other affiliated practice or entity (collectively referred to as “Cooley”). By accessing this content, you agree that the information provided does not constitute legal or other professional advice. This content is not a substitute for obtaining legal advice from a qualified attorney licensed in your jurisdiction and you should not act or refrain from acting based on this content. This content may be changed without notice. It is not guaranteed to be complete, correct or up to date, and it may not reflect the most current legal developments. Prior results do not guarantee a similar outcome. Do not send any confidential information to Cooley, as we do not have any duty to keep any information you provide to us confidential. This content may be considered Attorney Advertising and is subject to our legal notices.